SCHEMBL4966944

SCHEMBL4966944

Nc1ccc(NP(N)(=O)N2CCC[C@H](N)C2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.54
EPHX1 P07099 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4963263 0.88 DPP4 (0.53) DPP4GAARAB9A
SCHEMBL4964917 0.88 DPP4 (0.56) DPP4EPHX1GAARAB9A
SCHEMBL4966724 0.88 DPP4 (0.53) DPP4GAARAB9A
SCHEMBL4963531 0.88 DPP4 (0.56) DPP4RAB9A
SCHEMBL4968944 0.85 DPP4 (0.53) DPP4GAARAB9A
SCHEMBL4965133 0.85 DPP4 (0.50) DPP4EPHX1RAB9A
SCHEMBL4966659 0.85 DPP4 (0.50) DPP4GAA
SCHEMBL4964297 0.84 DPP4 (0.49) DPP4EPHX1GAA
SCHEMBL4966920 0.82 DPP4 (0.50) DPP4RAB9A
SCHEMBL4968301 0.78 DPP4 (0.46) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489088-B1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE NIPPON KAYAKU KK (JP) 2008-08-13 EP disclosed
US-7348318-B2 α-Amino-N-(diaminophosphinyl)lactam derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-03-25 US disclosed
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-07-28 US disclosed
EP-1489088-A1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE Nippon Kayaku Kabushiki Kaisha (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative DNPEP, PEPD, ANPEP DPP4 8/4885EPHX1 1810/4885GAA 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.